MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Immune Design Corp Company Profile (NASDAQ:IMDZ)

Consensus Ratings for Immune Design Corp (NASDAQ:IMDZ) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $34.00 (127.12% upside)

Analysts' Ratings History for Immune Design Corp (NASDAQ:IMDZ)
Show:
DateFirmActionRatingPrice TargetActions
8/18/2015Leerink SwannInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Jefferies GroupReiterated RatingBuy$29.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2015Jefferies GroupUpgradeHold -> Buy$32.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2014Jefferies GroupDowngradeBuy -> Hold$15.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Wells Fargo & Co.Initiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Jefferies GroupInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/5/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha